In 1975 the state of California enacted a bill which severely restricted the conditions under which psychiatrists could use E@T, and by 1977 seven other American states had adopted similar legislation. Although it was difficult for us in Britain to under stand the emotional and political background to this legislative activity the implied threat of similar restrictions closer to home led to a resurgence of professional and scientific interest in ECT in Europe as well as in North America. Several controlled trials have been carried out since that time, interest in its mode of action and side effects has blossomed, national associations have surveyed the opinions and practice of their members, and numerous reviews and editorials have been published. Indeed, so many good reviews have been published in the last six years that the need for another has to be justified. The justi fication, if such there be, is that most of the research generated by this new wave of interest in ECT has now been completed, and although for the most part its results confirm those of earlier work they do have some important clinical implications as well as suggesting where future research priorities should lie.
The Efficacy of ECT
(a) Depressive illness The most fundamental question to be asked of any treatment is whether it works and in the case of ECT the issue has been given added importance by a series of widely publicised assertions to the effect that it is an â€˜¿ unproven treatment' which, if it works at all, does so by frightening or punishing the patient or by damaging his memory. In fact, the evidence that ECT is an effective treatment for severe depression is strong and comes from many sources. When it first came into widespread use in the 1940s its effects were so dramatic that those who knew from personal experience what untreated melancholia had been like beforehand never doubted its efficacy. Slater (1951) demonstrated that its introduction was associated with a major reduction in mortality, and Post (1978) recently recalled its 265 almost miraculous effect on melancholic patients who had previously had to be tube fed twice a day for years on end. To another psychiatrist with memories of that era, looking back on all the therapeutic innovations of the last forty years from insulin to phenothiazine and antidepressant drugs, ECT still remains â€˜¿ the most important advance in treatment in our time ' (Rollin, 1981) .
Partly because it was so obviously effective and came into widespread use before the double blind trial was introduced to clinical medicine, and partly because of the practical and ethical difficulties of conducting a double blind trial of a treatment which involves repeatedly rendering the patient unconscious, the most important clinical trials of ECT were not conducted blind. They were, however, based on the more fundamental requirement of random allocation to alternative therapies. In the 1960s two large multi centre trials of the treatment of depressive illness were carried out, one in America, the other in England. In both over two hundred inpatients were randomly allocated to treatment with ECT, imipramine, phenel zinc or placebo. In the former (Greenblatt et a!, 1964 ) the proportion of patients showing â€˜¿ marked improve ment' after eight weeks was significantly higher for ECT than for any of the other groupsâ€"76 per cent, compared with 50 per cent for phenelzine and 49 per cent for imipramine. In the latter (Medical Research Council Clinical Psychiatry Committee, 1965) ECT was more effective then phenelzine and more effective than imipramine in women, though not in men. It also acted much faster than the drugs, so that at the end of five weeks the proportion of ECT patients who had been discharged from hospital was twice as high as for either drug. Several other random allocation trials comparing ECT and antidepressant drugs have been carried out, usually because the authors wanted to use ECT as a yardstick against which to measure the efficacy of a new drug. Again, ECT was almost invariably superior (e.g. Carroll et a!, 1970; Herring ton et a!, 1974) .
Despite the practical and ethical difficulties of conducting conventional double blind trials of EC1' several were carried out in the 1950s and 60s. Barton (1977) reviewed six published between 1956 and 1966. In each a control group received either the full ECT regime apart from the passage of the electric current or at least barbiturate anaesthesia. Outcome was better in the ECT group in all six, though in two the trial was based on too few patients for the difference to be statistically significant. Although several of these studies had methodological shortcomingsâ€"alter native rather than random assignment to the ECT and control groups, the inclusion of schizophrenic as well as depressed patients, or simply having too few patientsâ€"their unanimity is impressive. By the mid 1960s the evidence that ECT was an effective treatment for severe depression was quite strong enough to justify the phrase â€˜¿ substantial and incontrovertible' used in the Royal College of Psychiatrists (1977) report, and under normal circumstances that would have been the end of the matter. However, a widely publicised (but probably fictitious) report in World Medicine of a hospital whose staff did not realise for two years that their new ECT machine was not working, and political developments in the United States, made it clear that circumstances were not normal. As a result in the last five years four further double blind trials of ECT have been mounted in Britain alone.
In each of these patients with severe depressive illnesses were randomly allocated to treatment either with real or with â€˜¿ simulated' ECT (i.e. the full ECT regime apart from the actual passage of an electric current across the head). The first was by Freeman et a! (1978) in Edinburgh. These authors compared two groups of 20 patients, one of whom received bilateral ECT twice a week while the other received two simulated treatments in the first week and real treatments subsequently. At the end of the first week the patients receiving real ECT showed a significantly greater improvement on the observer rating and one of the two self-report ratings than those receiving simulated ECT. Thereafter, by which time both groups were receiving real ECT, there were no significant differences between them. However, the total number of treatments was left to the discretion of the clinicians concerned and, significantly, it transpired that the patients starting with two simulated treatments required more treatments than those receiving real ECT throughout (7.15 against 6.0, and P <.05).
The second trial, by Lambourn and Gill (1978) in Southampton, produced a quite different result. Two groups of 16 patients received either six real (unilateral) or six simulated ECT, each being given over a fort night at a rate of three/week. Although both groups improved on nearly all measures, and the overall improvement in Hamilton scale scores was somewhat greater in those receiving real ECT, the only sig nificant advantage for real ECI' lay in the relief ofâ€¢ hypochondriacal symptoms and was probably for tuitous.
The third trial, by West (1981) at Sutton Hospital, indicated a clear-cut superiority of real over simulated ECI'. Twenty-two severely depressed patients received one or other of these treatments twice a week for three weeks. The eleven receiving real ECT showed a striking improvement, apparent after one week, on self report, nurses' and psychiatrists' ratings (P <.001 for all three). Those receiving simulated ECT did not improve at all. The trial design allowed patients who had not responded to their first six treatments to be transferred to the other group in week four and when the code was broken at the end of the trial it emerged that this option had been used for ten of the eleven patients who had started on simulated ECT, but for none of the eleven receiving real ECT. Moreover those ten patients improved significantly, on self report, nurses' and psychiatrists' ratings, as soon as they did receive real ECT.
The fourth trial, at Northwick Park, indicated that real ECT was significantly more effective than simulated ECT, but only moderately and temporarily (Johnstone et al, 1980) . Seventy patients were randomly allocated to receive either 8 simulated or 8 real ECT at a rate of two/week. Both groups improved steadily during the course of treatment. At the end of the four week course the improvement in Hamilton scores was significantly greater (P <.01) in the real ECT than in the simulated ECT group but this advantage was modest and restricted to patients with delusions. It was also short-lived, for at one month and six month follow-up there were no significant differences between the two groups.
There are a number of possible explanations for the very varied outcome of these four trials, though none is entirely convincing. The first is the type of ECT used. The Southampton trial, the only one of the four in which real ECT proved to be no more effective than simulated ECT, used a brief pulse stimulus and right unilateral electrodes. The other three all used a conventional sinusoidal wave form and bifrontal electrodes. Although other evidence does not support this it is possible that the brief pulse unilateral technique is relatively ineffective. It is also possible, in the absence of EEG or EMG monitoring, that the authors were mistaken in thinking that every patient had a bilateral convulsion on every occasion. The second possibility is that, despite all precautions, the preconceptions of those responsible for the conduct of the four trials somehow influenced their findings.
At all events it is the writer's impression-that the result of all four reflected the initial hopes, or expec tations, of their architects. The third possibility is that there were important differences in the types of patients entering the four trials, and in their suitability for ECT. Certainly it is surprising that only 15 (21 per cent) of the 70 patients in the Northwick Park trial had had ECT previously, compared with 55 per cent, 59 per cent and 66 per cent in the Edinburgh, Sutton and Southampton trials. The 70 patients in this trial also comprised 64 per cent of all patients â€oe¿ aged 30â€"69 years who required inpatient treatment for depressive illness and were admitted to Northwick Park Hospital under the care of the participating psychiatristsâ€•,an extremely high proportion when one considers that a further 18 per cent would have been included had they not refused or been poor anaesthetic risks. These unusual proportions raise the possibility that many patients who would not normally have received ECT entered this otherwise well-designed trial and perhaps explain why those who received only simulated E@T recovered so quickly.
Because of their conflicting findings, and the lack of any wholly satisfactory explanation of this, these four trials corporately do not significantly strengthen or weaken the previous evidence for the efficacy of ECT in depressive illness. However, that previous evidence was strong.
The most important finding of the Northwick Park trial is the lack of any difference between the real and simulated ECT groups at one and six months follow up rather than the modest difference in outcome between the two at the end of treatment. Although it has long been accepted that its high relapse rate is one of the most serious limitations of ECT few other trials â€"¿ apartfrom that of Taylor and Fleminger (1980) in schizophrenia, which produced exactly the same result â€"¿ have involved a comparable follow-up period. Even though over-generous inclusion criteria and a failure to use tricyclic antidepressants routinely afterwards may have been responsible for the poor long-term response in this instance it is important that any future trials should involve a substantial follow-up period. The duration of benefit is, after all, just as important as its initial magnitude.
(b) Schizophrenia
Although Meduna's convulsive therapy was origin ally introduced as a treatment for schizophrenia, and Cerletti's electroconvulsive therapy was extensively used for that purpose in the 1940s and 1950s, the formal evidence that it is an effective treatment for this condtion has never been strong. Perhaps the best evidence is provided by an ambitious clinical trial conducted by May (1968) at the Camarillo State Hospital in California. Two-hundred and twenty-eight young adults who had received no significant treatment beforehand and with prognoses in the â€˜¿ middle third' of the range were randomly allocated to one of the five treatmentsâ€"phenothiazines;
analytically oriented psychotherapy; phenothiazines and psychotherapy; ECT; and milieu therapy (i.e. no treatment other than the general ward programme). Men in the ECI' group received an average of 18 and women an average of 25 treatments. Unless the patient recovered beforehand treatment was continued for a minimum of six months and a maximum of twelve. Outcome was assessed by the discharge rate and length of hospital stay and independent ratings were made by nurses, residents and supervising psychiatrists. The results were not as good in the EC@ patients as in the two groups who received phenothiazines, but were significantly better than in those who received either analytically-oriented psychotherapy or milieu therapy. Assessments were not double blind but the many different estimates of outcome available agreed well with one another.
Although this finding is of some theoretical interest it is not of great practical importance because almost all acute schizophrenics are currently treated with phenothiazines or other antipsychotic drugs in the first instance. If ECT is to have a useful role in the treatment of schizophrenia, therefore, it can only be because it is a more effective treatment than these drugs for some particular syndromes, such as cata tonia; or because it is effective in some patients in whom phenothiazines have failed; or because a combination of phenothiazines and ECT is more effective than phenothiazines alone. The first two of these possibilities have never been supported by convincing evidence, though both have had enthu siastic advocates in the past. Several studies have compared combined ECT and phenothiazines with phenothiazines alone and found the former to be superior, but most were rather poorly designed and also concerned only with immediate response (e.g. Childers, 1964) . Smith et al (1967) compared 29 patients who received twelve ECT as well as chlor promazine with 25 patients â€˜¿ concurrently selected', who received larger doses of chlorpromazine but no ECT. Those receiving the combined treatment had significantly less psychopathology at one, three and six weeks after treatment but these differences had gone by six months and twelve months. However, despite the loss of this early advantage those who received ECT were discharged sooner and also had a lower readmission rate. Taylor and Fleminger (1980) have recently des cribed a small but much better designed trial of the effect of ECT in combination with phenothiazines. Thirty-one patients with acute schizophrenic illnesses eleven recovered during this time. The remaining 20 were then randomly allocated to real or simulated ECT and received between 8 and 12 treatments at a rate of three/week while remaining on their original medication. Those receiving real ECT showed a significantly greater improvement at two, four and eight weeks, but this difference was completely lost by sixteen weeks. The trial suggests, therefore, that ECT has a significant beneficial effect in acute schizophrenia even in patients who are already receiving pheno thiazines, but that this is too short-lived to be of much practical importance. It is possible, though, that a longer course of ECT might have longer lasting effects. Certainly, it used to be widely believed that schizo phrenics usually needed between twelve and twenty treatments for maximum improvement.
In chronic schizophrenia it is generally agreed that ECT is of little value and this view is reinforced by an early clinical trial by Miller eta! (1953) . These authors randomly allocated 30 chronic schizophrenics to one of three treatmentsâ€"unmodified ECT; thiopentone anaesthesia; and non-convulsive electrical stimulation under thiopentone anaesthesia. The first (ECT) group received five treatments a week for three weeks and the others five treatments a week for four weeks. At the end of the trial there were no significant differences between the three.
(c) Mania
Although ECT was widely used for the treatment of mania before chlorpromazine became available in 1953, and was generally regarded as highly effective, no clinical trial was ever carried out to demonstrate its efficacy. The best evidence we have is a retrospec tive comparison by McCabe (1976) of 28 patients treated with ECT in the Iowa Psychopathic Hospital in 1945â€"49 and 28 other patients treated in the same hospital in 1935â€"41before ECT was available. Although the case notes suggest that the two groups were comparable in severity and duration of illness those receiving ECT had a lower mortality and left hospital sooner, and were also more likely to be improved at the time they did so. Impressive as these differences are, retrospective comparisons of this kind are no substitute for controlled trials. And, as in the case of schizophrenia, the important question is not whether ECT is better than no treatment but whether it has any advantage over chlorpromazine, haloperidol or lithium.
The Mode of Action of ECT As normally given ECT is a complex package involving the administration of three different drugs, â€˜¿ all with profound physiological effects, the passage of an electric current across the head, a period of unconsciousness, and considerable medical and nursing attention. It may also have a highly charged emotional significance for the patient. In principle, therefore, the therapeutic effect could be a function of any one, or any combination, of these elements. There is, however, compelling evidence that the induction of generalized seizure activity in the brain is the crucial element.
When Meduna first introduced his convulsive therapy he gave his schizophrenic patients injections of camphor, and later of Cardiazol, with the explicit intention of producing grand mal seizures. Cerletti subsequently developed his electroconvulsive therapy with the equally explicit intention of inducing seizures in a more reliable and less distressing manner. So it was assumed from the beginning that the seizure itself was the therapeutic agent. For some years both treatments were widely used., and ECT eventually supplanted Cardiazol not because it was thought to be more effective but simply because it was easier to administer and more humane. The procedure became more complicated in the 1950s when it gradually became standard practice to modify the fit by abolish ing the limb movements with suxamethonium, and to induce anaesthesia beforehand with an intravenous barbiturate. Formal experiments to determine which elements in the procedure were necessary for the therapeutic effect followed this innovation.
The comparative efficacy of modified and unmodified ECT was studied by Havens (1958) and Seager (1959) . In both trials substantial numbers of patients were randomly allocated to the two treatments and in neither was any significant difference found between them, which clearly indicates that limb movements and their metabolic sequelae are irrelevant to the thera peutic effect. Ulett et a! (1956) designed a more complicated trial. Eighty-four patients were divided into four equal groups matched for age, sex, diagnosis and education. The first received ECT (unmodified); the second had convulsions induced by a combination of a subconvulsive dose of hexazol and photic stimulation from a crater lamp stimulator; the third received subconvulsive photo stimulation (induced with smaller doses of hexazol and intermittent photo stimulation) sufficient to produce generalized myo clonus and paroxysmal brain activity but no fit; and the fourth acted as controls. So that patients as well as raters should be unaware of the differences between the regimes light seconal anaesthesia was induced in all four groups before entering the treatment room. All patients had three treatments a week to a total of between twelve and fifteen and outcome was assessed three days after the last treatment. The two convulsive treatments (ECT and photostimulation) combined yielded significantly better results than the were treated with phenothiazines for two weeks and two non-convulsive procedures combined, but there was no significant differences between ED.' and photostimulation or between subconvulsive photo stimulation and the controls. The authors concluded that â€˜¿ the grand mal seizure itself' is â€˜¿ the important agent in bringing about remission from affective disorder', though it should be noted in passing that 20 of their 84 patients were actually schizophrenics.
This conclusion is strengthened by the evidence of two double blind trials that convulsions induced by inhalation of the convulsant ether flurothyl (â€˜Indo klon') have the same therapeutic effects as electrically induced convulsions. Laurell (1970) compared groups of 29 and 30 patients with endogenous depression randomly allocated to flurothyl convulsive therapy (FCT) and ECT and found no significant differences in outcome. In a similar study Small ci a! (1968) randomly allocated 100 diagnostically heterogeneous patients to EC1' and FCT and likewise found no significant differences in outcome either in schizo phrenics or in patients with affectivÃ³ disorders.
Ottosson (1960) tackled the problem in an in genious way, by giving three groups of patients with endogenous depression ED' under different condi tions. All three received a muscle relaxant and light thiopentone anaesthesia but the first group received a supraliminal electrical stimulus (i.e. considerably greater than needed to produce a convulsion), the second a liminal stimulus and the third a liminal stimulus preceded by i.v. lidocaine (xylocaine), which has the effect of reducing the duration of convulsive activity in the brain without raising the convulsive threshold. The therapeutic effects of the liminal and supraliminal stimuli were indistinguishable, though the latter produced considerably greater memory dis turbance. But the therapeutic effect was considerably reduced in the patients who received lidocaine, suggesting once more that it is the convulsive activity in the brain that is responsible for the therapeutic action. This conclusion is also supported, of course, by the trials of Freeman ci a! (1978) and West (1981), described above, comparing ECT with simulated ECF.
The only important study in the literature which does not support this conclusion, apart from the trial of Lambourn and Gill (1978) already described, was conducted by Brill et a! (1959). These authors randomly allocated 97 male patients to one of five treatments: unmodified ED', ED' and suxametho nium, ECT and thiopentone, thiopentone alone, and nitrous oxide alone. All patients received three treatments a week, usually to a total of twenty. Detailed precautions were taken to keep the trial double blind and all groups were assessed in a variety of ways before and one month after the end of treatment. No significant differences were found between any of the five treatments, though unmodified ED' and ED' with suxamethonium tended to give the best results. The explanation of this surprising result probably lies in the choice of patients. Sixty-seven of the 97 were schizophrenics and another 14 had schizoaffective disorders, so only 16 had uncompli cated depressive illnesses. Moreover, the patients' duration of illness ranged from less than one month to over ten years and the authors themselves admitted that their patients were â€oe¿ heavily loaded with chronic schizophrenicsâ€•. It was probably also a mistake to wait a month after the last treatment before rating outcome.
The possibility that the crucial therapeutic in gredient might be the temporary disturbance of memory produced by the treatment was seriously considered in the 1950s but is difficult to reconcile with the results of Ottosson's experiment, it is equally incompatible with the substantial evidence which has accumulated subsequently that the thera peutic effects of unilateral and bilateral electrodes are equivalent, despite the fact that the former consistently produces much less memory impairment than the latter (D'Elia and Raotma, 1975; Heshe cia!, 1978) .
Most authors, reviewing the accumulated evidence of the last thirty years, have had no hesitation in agreeing with Ulett and Ottosson that the convulsion is the therapeutic agent. The American Psychiatric Association's Task Force, for example, concluded that â€˜¿ the only demonstrated absolutely necessary change is a generalized electrical seizure of the central nervous system' (American Psychiatric Association, 1978) . The only dissent is voiced by Crow (1979) who maintains that the role of the convulsion â€˜¿ has never been unequivocally established'. It is true, as Crow says, that many of the studies described here have defects in design. Ottosson's patients were not randomly allocated to his three groups, Ulett's patients were diagnostically heterogeneous and several of the older studies used rather crude measures of outcome. But such shortcomings do not entitle us to disregard a dozen studies of different kinds which all point to the same conclusion, particularly when there is no plausible alternative.
There is also other evidence from animal studies. Dorworth and Overmier (1977) induced a state of â€˜¿ learned helplessness' in 19 dogs by giving them a series of unavoidable electric shocks while confined in a harness. The ten dogs showing the most severe impairment of escape/avoidance learning were then divided into two groups. The first was given a series of six electrically induced convulsions (EQS), without anaesthetic, over a 72 hour period. The second received exactly the same manipulations apart from the six EQS. Four days later the escape/avoidance responses of both groups were retested. The ECS group showed marked improvement; the controls did not. Petty and Sherman (1980, personal communica tion) have similarly demonstrated that learned helplessness in rats can be reversed by 10 ECS over five days but not by subconvulsive shocks.
Modigh in Gotenberg and Green in Oxford have investigated the pharmacological effects of inducing repeated convulsions in experimental animals with an electric shock applied through ear-clip electrodes (ECS). Modigh (1975) found that, although a single ECS was ineffective, daily ECS for a week produced increased locomotor activity for several days after the last convulsion. Locomotor responses to apo morphine and clonidine were also increased after pre treatment with reserpine, suggesting that repeated ECS enhances the postsynaptic sensitivity of dopa minergic and noradrenergic receptor systems. Green and his colleagues gave ECS to rats daily for ten days and found that the animals subsequently showed greater hyperactivity than controls when given tranylcypromine with either 1-tryptophan or I DOPA (Evans ci a!, 1976). 5-hydroxytryptamine synthesis and accumulation were not affected and brain con centrations of noradrenalin and dopamine remained unchanged. Animals subjected to repeated ECS also showed enhanced hyperactivity after administration of the putative serotonin agonist 5 methoxy N,N dimethyltryptamine, suggesting that ECS increases postsynpatic responses to stimulation of 5-hydroxy tryptamine and dopamine receptors. Subsequent studies showed that repeated ECS enhanced the locomotor activity produced by methamphetamine, and the circling produced by methamphetamine and apomorphine in animals with unilateral nigrostriatal lesions, again suggesting an effect on postsynaptic sensitivity (Green ci a!, 1977) . This series of behavioural changes could be produced by five ECS in ten days, or by eight in 17 days, but not by sub convulsive shocks or by eight ECS in one day. it made no difference whether the convulsions were induced by a sinusoidal alternating current or a discharging condenser, whether they were produced electrically or by the convulsant ether flurothyl, whether the electrodes were applied unilaterally or bilaterally, or whether or not a neuromuscular blocking agent was used (Costain ci a!, 1979).
The importance of this work is that it demon strates a series of behavioural changes which are produced by repeated convulsions induced in similar ways and over a comparable time scale to human ED', but not by single shocks, subconvulsive shocks or multiple shocks within 24 hours. Moreover, the pharmacological characteristics of these behavioural changes suggest that they are produced by changes in central neuronal transmission similar to those produced by antidepressant drugs. Although none of these effects lasts for longer than about six days, whereas the effects of clinical ED' are relatively permanent, it must be remembered that in these experiments the functioning of a presumably normal mouse or rat brain is being temporarily disturbed, while in the clinical situation the function of a presumably abnormal brain is being restored to normal. A more serious problem is that so far no one has succeeded in demonstrating any comparable enhancement of monoaminergic transmission in human subjects after ED'. Slade and Checkley (1980) , for example, failed to demonstrate any increase in the growth hormone response to either clonidine or methyl amphetamine after seven bilateral ED' and Modigh was likewise unable to demonstrate any increase in the growth hormone response to methyl amphetamine.
Risks and Adverse Effects of ECT
With or without a general anaesthetic ED' is a surprisingly safe procedure. Strensrud (1958) studied the mortality and neurological morbidity of a series of 893 women treated with ED' (or in some cases chemically induced convulsions) at Gaustad Hospital in Norway in 1938â€"56. Although this population received a total of 24,562 treatments there were no deaths during or immediately after treatment and no patients were left with neurological deficits. There were three deaths in which treatment may have played some part but all three had pre-existing brain disease Pick's disease, general paralysis and epilepsy/mental deficiency. More recently Heshe and Roeder (1976) have studied the use of ED' in Denmark in the twelve month period from April 1972 to March 1973. Twenty-two thousand two hundred and ten ED' were given in 3,438 courses of treatment, an average of 6.5 treatments to a course. Only one death was reported and the relationship of this to the treatment was doubtful. The incidence of other side effects was also extremely low, and no higher when the anaesthetic was given by a psychiatrist or a nurse than when it was given by an anaesthetist. In England and Wales between 1957 and 1966 there were an average of 3.6 deaths/year associated with ED' but no estimate of the size of the population at risk is available (Granville Grossman, 1971) . Death when it does occur is usually due either to myocardial infarction or to the onset of a ventricular arrhythmia, probably produced by vagal hyperactivity. The dangers of any treatment have, of course, to be set against those of the untreated illness and of alternative therapies, and in fact the advent of ED' was associated with a steep fall in the hospital mortality of depressive illness (Slater, 1951) . It has also been shown that the overall mortality of depressed patients over a three year period is lower in those treated with ED' than in those treated with psychotherapy or small doses of antidepressant drugs (Avery and Winokur, 1976) .
In the past fractures, mainly of mid-thoracic vertebrae, and dislocations, particularly of the jaw, were a common complication, affecting up to 30 per cent of patients in some series. Since suxamethonium came into routine use, however, complications of this kind have virtually ceased and even patients with serious spinal or other orthopaedic disorders can be given ED' with relative impunity.
The occurrence of sporadic grand mal fits for the first time in the weeks or months after a course of ED' has been reported several times (e.g. Blumenthal, 1955; Klotz, 1955; Stensrud, 1958) . In many cases, though, the patients had either received other treat ments like insulin coma therapy or tricyclic anti depressants which may have been partly or wholly responsible, or were known or suspected to have organic brain disease. In most of the early reports the patients had also received far longer courses of ED' than are normally given now. The analogy of the kindling phenomenon has recently revived interest in the relationship between ED' and epilepsy but a survey of 166 patients, who between them had re ceived at least 2,789 treatments, mostly in the previous two years, revealed only four people who had developed fits for the first time after ED' and in only two of these was it the likely cause (Blackwood et a!, 1980). There is general agreement that fits provoked by ED' rarely if ever persist for longer than a year, and so rarely require treatment.
A course of ED' almost invariably produces extensive LEG changes. If bilateral electrodes are used paroxysmal delta activity starts to appear in the frontal leads after the first two or three treatments and becomes steadily more prominent and extensive thereafter. A minority of patients also develop spike foci. This generalized delta activity wanes rapidly after the end of the course and in most patients the EEG has returned to normal within three months (Klotz, 1955) ; In the past considerable interest was taken in the possibility that these dramatic changes might be different in responders and non responders. There have been claims, for example, that responders develop widespread delta activity at an earlier stage (Fink and Kahn, 1957) , or show a greater increase in â€˜¿ spectral energy in the 9â€"12Hz range (Kurland ci a!, 1976), or that delta activity is more rapidly extinguished by thiopentone in those who subsequently relapse (Roth ci a!, 1957) but none of these relationships has ever been confirmed. Whether ED' ever produces enduring EEG changes, and if so under what circumstances, remains an open question.
The common immediate side effects of ED' are headache, confusion and memory disturbance, though the headache and confusion are usually mild and last only an hour or two. Impairment of memory is invariably present if appropriate testing is done, though many patients remain unaware of it. In a recent survey of a group of 166 patients the com monest side effects recorded in medical or nursing notes were headache (16 per cent), confusion (9 per cent) and memory disturbance (7 per cent) (Freeman and Kendell, 1980) . A rather different picture emerged, however, when these patients were asked a year later about the side effects they remembered. Twenty per cent could remember none, but 64 per cent reported some impairment of memory, and 48 per cent remem bered having a headache and 27 per cent feeling confused on at least one occasion. Spencer (1977) asked 50 Australian patients to fill in a questionnaire about the things they disliked about ED' while they were half-way through a course. Loss of memory afterwards was their most frequent complaint (36 per cent) but after that came waiting for treatment, not understanding what was going on and fear of not losing consciousness rather than complaints of side effects as such.
The short term effect of ED' on memory has been studied many times. There is a retrograde component, most noticeable for recent events, and also difficulty in retaining newly acquired information. it is well established that this memory impairment and the associated confusion are less severe and more short lived when ED' is given unilaterally to the non dominant hemisphere than when bilateral electrodes are used (Heshe ci a!, 1978). It is also well established that if the electrodes are placed over the non-dominant hemisphere there is a selective impairment of non verbal learning, and a selective impairment of verbal learning if they are placed over the dominant hemi sphere (Halliday ci a!, 1968; Squire and Slater, 1978) . These disturbances wane rapidly after the end of treatment in the same way as the EEG changes described above.
Transient impairment of memory for a few weeks, or even for two or three months, is usually no more important or distressing than a dry mouth or many of the other common side effects of drug treatments. A lasting impairment restricted to events taking place at the time of treatment would also be relatively unimportant; indeed many people might be glad to have a rather hazy memory of a painful and distressing illness. But a permanently impaired ability to recall more distant events or, worse still, to register new information subsequently, would be much more serious and a powerful objection to the treatment.
Because temporary impairment of memory is almost universal, and complaints by former patients that their memories have been permanently affected by ED' are by no means rare, many attempts have been made to detect lasting effects. The great majority of these have failed to demonstrate any persistent impairment a few months after the end of a course. Many of the early studies had serious shortcomings which weakened their otherwise reassuring con clusions. Some used single tests or a restricted range of tests which might have missed deficits in other areas. Others, like the oft quoted study of Cronholm and Molander (1964) , demonstrated only that test per formance was as good a few weeks after a course of ED' as it had been immediately beforehand, ignoring the fact that depression itself produces extensive cognitive impairment and that this finding might therefore be due to the substitution of impairment from ED' for impairment from depression.
Recently, in response to popular concern, several carefully designed studies have been carried out using a wide range of cognitive tests and control groups of depressives treated in other ways. Most have still failed to elicit any evidence of persistent impairment, either of memory or of any other cognitive function. Squire and Chace (1975) tested 16 patients who had received bilateral and 10 who had received unilateral ED' six to nine months before, and 12 control patients who had never had ED'. All 38 were visited at home on three occasions and given six different tests of delayed retention and remote memory, involving verbal, visual and casual learning. Although 63 per cent of the bilateral ED' patients (compared with only 30 per cent of the unilateral patients and 17 per cent of the controls) were convinced that their memories were worse than they had been previously no significant differences were found between the three groups on any of the six tests, and the test scores of those with memory complaints were no different from those without.
Weeks ci a!(l980) gave a battery of 19 tests covering a wide range of cognitive functions to 51 depressives before they received ED' and again one week, three months and six months after the end of the course. The same tests were given to 51 other matched depressives who did not receive ED'. The ED' patients received an average of 7.2 treatments, 15 with unilateral and 36 with bilateral electrodes, and by good fortune there were no significant differences in the medication received by the two groups. Partly because their initial performance was impaired by depression the ED' patients did not score worse on any of the 19 tests one week after their last treatment than they had done before starting. Three months later there were significant differences between the ED' and non-ED' groups on only two of the 19: the ED' patients were unable to remember the names of famous personalities of the l970s as well as the controls, but performed significantly better on another test. At six months there was only one significant difference, the ECT group performing better than the controls on the Logical Memory Test.
More recently, Johnstone ci a! (1980) have reported the main findings of the cognitive testing carried out in conjunction with the Northwick Park ECT trial. Although impairment was clearly demonstrable on several tests during and immediately after treatment in the real ED' group there were no significant differences on any test between the scores of the real and simulated ED' groups six months later. Although this study was based on fewer patients and employed a more restricted range of tests than that of Weeks et a! it was better designed in two important respects: allocation to the real and simulated ED' groups was random, and the analysis was confined to patients who had never received ED' before. Corporately, there fore, these three studies appear to provide convincing evidence that ED', at least as currently used, does not result in any lasting impairment of memory or of any other cognitive function.
There is, however, some important evidence that under certain circumstances long-term impairment can occur. Thirty years ago Janis (1950) studied the effect of ED' on the minutiae of past personal memories. He interviewed 19 patients before starting ED' to obtain detailed information about events, important and trivial, in their past lives and then interviewed them again four weeks after their last treatment. He found that all 19 were unable to recall some of the memories they had described in the pretreatment interview, and in the five patients interviewed once more six to ten weeks later most of these deficits were still present. Eleven control patients, matched for age and education, were also interviewed on two occasions the same interval apart but in them memory lapses were almost non-existent. The majority of both groups were schizophrenics, however, and the ED' group received an average of 17 unmodified treatments at a rate of three/week, a larger number at a higher rate than is usual nowadays.
Squire et a! (1981) have recently attempted to replicate these long neglected findings. They tested the detailed memory of a series of public and private events of 43 depressed patients who all received eight or nine bilateral ED' at a rate of three/week and a small control group of seven depressives treated in other ways. The tests were administered before starting ED', shortly after the fifth treatment and one week and seven months after the last treatment. Their results, based partly on spontaneous recall and partly on recognition, indicated that one week after the end of a course of ED' memory was disrupted even for events which had occurred many years previously. At seven months distant memory had recovered com pletely but the patients' ability to recall the events of the day of their admission to hospital (2 to 36 days prior to starting ED') was still impaired, and to some extent their memory of public events (the Watergate scandal) that had taken place two to three years before had not recovered fully either.
A study by Freeman ci a! (1980) of 26 former patients who were convinced that the ED' they had received in the past had permanently harmed them in some way is also relevant to this issue. Most of these people, w@howere mainly identified by a newspaper appeal, had complaints about their memory: either that they had gaps in their memory of events which had taken place months or years before they had ED', or that since that time they had had more difficulty remembering names, phone numbers etc. On cognitive testing none of the 26 was severely impaired, but as a group their scores on 7 of the battery of 19 tests were significantly worse than those of matched controls. The ED' complainers had more depressive symptoms than the controls, and more were currently taking psychotropic drugs, but analysis of variance/ covariance suggested that only part of their cognitive deficit was accounted for by these differences.
Despite the lack of evidence it has long been suspected that ED' does have permanent effects on memory in some people. This has always been a widespread belief amongst those who have had the treatment themselves and many psychiatrists have shared this view. Forty-one per cent of the 3,000 American psychiatrists who completed the American Psychiatric Association's questionnaire on ED' agreed with the statement that â€oe¿ It is likely that ED' produces slight or subtle brain damageâ€•. (American Psychiatric Association, 1978) . Despite the negative results of other studies the findings of Janis, Squire and Freeman described above provide fairly convinc ing evidence that past memory can be permanently disrupted under some circumstances. The losses are not very serious or extensive and are restricted for the most part to events shortly before the time of treat ment. There is no evidence that the capacity to acquire new memories is impaired in any way. It is important to recognize, however, that the patients studied by Janis and Squire ci a! had had comparatively long courses of bilateral ED' given at a rate of three/week. It is well established that short-term memory impair ment is greater with bilateral than with unilateral electrodes, and that its severity increases with the number and frequency of treatments. Complaints of permanent ill effects are also much more frequent after bilateral than after unilateral treatment (see Squire and Chace, 1975 , for example). Whether unilateral treatment ever produces lasting sequelae is still uncertain, but there is no evidence that it does and the considerations referred to above suggest that it is much less likely to do so than bilateral treatment. Indeed there is no evidence at present that bilateral treatment has lasting ill effects if it is only given twice a week. Most of the patients studied by Weeks et a! (1980) received bilateral ED' twice a week and they showed no impairment at either three or six months on a test of past personal memory based on 48 separate incidents from various stages in their past lives.
Even if we accept, as we must, that some patients do suffer minor but permanent memory losses for the period shortly before they had ED' this impairment is hardly serious enough or common enough to explain the widespread conviction of former patients that their memories have been permanently affected. It is likely, as Squire and Chace suggested, that the temporary impairment of memory produced by ED', particularly bilateral ED', focuses people's attention on lapses of memory they would previously have ignored or not even noticed, and that this heightened awareness of normal failings is the main reason why complaints of poor memory are so common after wards. It is well known in. other contexts that there is little correlation between subjective complaint and objective impairment where memory is concerned. Indeed there may even be an inverse relationship between the two (see, for example, Kahn ci a!, 1975). And, of course, recurrent depression commonly produces complaints of failing memory as well.
Despite early reports of cerebral oedema, neuronal degeneration, gliosis and petechial haemorrhages in the midbrain there is no evidence either from experi mental ECS in laboratory animals or histological studies of patients' brains that electrically induced convulsions produce cerebral damage of any, kind unless very large numbers of shocks are given in a short space of time. There is evidence, however, of a temporary breakdown of the blood/brain barrier. Using horseradish peroxidase as marker substance Bolwig ci a! (l977b) showed that even a single ECS produced staining of brain tissue in some animals. This was abolished, however, by transection of the cervical cord, suggesting that this increased perme ability is secondary to the rise in blood pressure accompanying the convulsion. Bolwig and Hertz also showed that' the permeability of the blood brain barrier to small molecules increased temporarily in psychiatric patients receiving ED' (Bolwig ci a!, l977a). However, as similar changes in both perme ability and cerebral blood flow were produced simply by breathing 3 per cent CO2 they concluded that the increased permeability was probably secondary to increased blood flow in both cases, due either to a stretching of endothelial cells in cerebral vessels or to the opening of new capillaries.
Hamilton ci a! (1979) have recently claimed that the temporary impairment of cognitive function associated with ED' correlates highly with the magnitude of the associated rise in blood pressure. If confirmed this is potentially important, because it suggests that the cognitive impairment may also be secondary to increased permeability of the blood/brain barrier, and possibly preventable by drugs which abolish or reduce the rise in blood pressure.
The Clinical Indications for ECT
In the l940s and early 1950s ED' and other convulsive therapies were the most effective treatment available for most acute psychosesâ€"schizophrenic, depressive, manic and organicâ€"and were therefore very widely used. The introduction of chlorpromazine in 1953 and imipramine in 1957, and the wide range of phenothiazines, tricyclic antidepressants and butyro phenones which followed them, provided effective drug therapies for many of these illnesses. More recently the widespread prophylactic use of lithium carbonate and long-acting phenothiazines and thio xanthenes has prevented other psychoses from developing. As a result the clinical indications for ED' have been shrinking steadily for the last twenty years and its declining use is well documented throughout the world. Recent surveys suggest that in the United States and in Sweden between 3 per cent and 5 per cent of all psychiatric inpatients still receive ED', though in North America and some European countries this percentage is being eroded further by legislative restrictions and unfavourable publicity. At the same time as overall use has fallen the range of patients treated has become more limited, and increasingly restricted to those with severe depressive illness.
(a) Treatment of depression
The tricyclic and tetracyclic antidepressants are now the mainstay of treatment for most depressive illnesses, preferably in combination with one of the forms of psychotherapy which have been shown to enhance or complement their effect (Weissman, 1979 Although the results of these studies were conflicting in many points of detail there was general agreement that the classical symptoms of so-called â€˜¿ endogenous' depression (severe depression of acute onset, diurnal variation of mood, retardation, early morning waken ing, loss of weight, appetite and libido etc.) predicted a good response while those of â€˜¿ neurotic' depression did the reverse. Retardation in particular was consistently associated with a good response. Since this time it has been an almost unanimous view that ED' should not be given to patients lacking any psychotic or endogenous features, partly because of this evidence and partly also because of a widespread impression that the majority of patients complaining of severe side effects during or after ED' were people with neurotic symptoms and personality traits. For tricyclic non-responders with predominantly neurotic symp toms, therefore, a monoamine oxidase inhibitor or some form of psychotherapy is a better second-line treatment than ED'. Certainly it is in patients of this type that the evidence for the antidepressant activity of these drugs is strongest (Robinson ci a!, 1973). For those with classical endogenous symptoms, or at â€˜¿ least with more endogenous symptoms than neurotic ones, ED' remains the treatment of choice if tricyclic drugs are ineffective and this is probably its main use in contemporary clinical practice.
There are a number of circumstances, though, in which ED' is the most appropriate initial treatment.
In some patients with recurrent episodes of depression it is clear from their history that they have rarely if ever responded to tricyclic or other drugs, but have generally responded to ED' subsequently. If this sequence of events has been observed two or three tenance treatment to patients who had already recovered from a manic or depressive illness in the belief that this reduced the likelihood of relapse. The frequency of administration varied from once a week to once a month and as treatment was often continued for several years some patients received several hundred convulsions during this period. The efficacy of this practice was never established by a random allocation trial, though there were claims that psycho tic patients who accepted maintenance ED' once a month had a much lower relapse rate subsequently than those who did not (e.g. Karliner and Wehrheim, 1965) . Once it was established that lithium salts were an effective prophylactic treatment for both bipolar and unipolar illnesses maintenance ED' was largely abandoned, and rightly so in view of the risks and inconvenience involved. There might, however, still be a case for it in rare patients who have frequent, disabling manic or depressive swings despite lithium.
(d) Treatment of schizophrenia ED' is used much less often now than in the past, largely because it has been replaced by phenothiazines and other drugs inhibiting dopaminergic transmission. It is often said to be the most effective treatment for catatonia but there is little published evidence for this belief and in any case catatonia has become un common in industrialized countries. The question of using ED' arises mainly in the treatment of patients with acute schizophrenic illnesses who have not responded to drug therapy and remain too ill to leave hospital. Although the studies of Smith et a! (1967) and Taylor and Fleminger (1980) described above suggest that the benefits of giving it in addition to phenothiazines are fairly short-lived a trial of ED' is a reasonable expedient under these circumstances, particularly if the patient also has affective symptoms. How many treatments should be given is much harder to decide. It was a widespread clinical belief in the past that schizophrenics required longer courses than depressives and that the mode of action was different in the two conditions, but neither of these beliefs was ever based on anything more substantial than majority opinion. There is no case for giving ED' to chronic schizophrenics. Even when enthusiasm for the treatment was at its height it was widely accepted that results were poor in chronic illnesses, and this was confirmed by the trial of Miller ci a!(l953).
(e) Other conditions
All potent and effective treatments, from steroids to antibiotics, are at risk of being used by uncritical enthusiasts in inappropriate circumstances. ED' is not exempt from this hazard and there are still occasional reports of its use in the treatment of anorexia nervosa, times it is obviously sensible to give ED' straight away and not prolong the patient's illness for several weeks administering a drug which is unlikely to help. Secondly, severe melancholic illnesses, particularly those with deep retardation, or accompanied by nihilistic or paranoid delusions, respond poorly to tricyclic drugs but often respond dramatically to ED'.
The evidence that deluded depressives usually respond poorly to drugs comes from several sources. The fact has been noted in passing in two clinical trials of antidepressant drugs (e.g. Hordern ci a!, 1963; Glassman ci a!, 1975). It has also been found that depressives with a score of 9 or more on the Newcastle Scaleâ€"in effect those with the most severe psychotic illnessesâ€"respond to amitriptyline less well than those with scores of four to eight (Rao and Coppen, 1979) . And it has been found that patients with a mixture of depressive and either schizophrenic or paranoid symptoms respond poorly to amitriptyline, chlor promazine or the two combined (Brockington ci a!, 1978). Although it has been claimed by Quitkin ci a! (1978) that deluded depressives will respond to very high doses of imipramine the claim is unconfirmed and in any case many patients, the elderly in particular, cannot tolerate such doses. It is often advisable, therefore, to give ED' straight away to patients with nihilistic or paranoid delusions, and also to patients with schizophrenic symptoms as well as depressive ones. Finally, there are some situations in which it is vital to remove the patient's symptoms as quickly as possible, either because they are ceasing to eat and drink, or because of the risk of suicide, or simply because they are suffering so much. There is good evidence that ED' acts considerably faster than tricyclic drugs (e.g. Medical Research Council, 1965; Coryell, 1978) and in situations such as these one should have no hestiation in giving it immediately for that reason alone.
(b) Treatment of mania
Although in the past ED' was widely, and success fully, used for the treatment of mania it is rarely used now because it has been supplanted by drugs of proven efficacyâ€"phenothiazines, butyrophenones and lithium salts. Whether there are any circumstances in which it should still be used is uncertain because no adequate clinical trial comparing it with any of these drugs has ever been carried out. It is possible that there are situations in which ED' is still superior, and in the absence of formal evidence either way a reasonable case can be made for giving it to patients with severe manic illnesses who do not respond, or not quickly enough, to chlorpromazine, haloperidol or lithium.
(c) Maintenance ECT In the l950s ED' was frequently given as a main obsessional illnesses, organic confusional states, â€˜¿ psychogenic' pain and other conditions besides. Unless there are good grounds for believing that the patient is also depressed such use has neither theoretical justification nor empirical support and is therefore inappropriate. In particular, ED' should not be given to patients with organic psychoses, though mild cognitive impairment is not a contraindication to its use in elderly depressives. [The belief that it is an effective treatment for delirium is based largely on a misunderstanding of the Danish literature, for the Danish term dc!irium acutum refers to what Anglo American psychiatrists would call florid acute schizophrenia.] Finally, ED' should never be used simply to control aggressive or violent behaviour. Its occasional use for this purpose in the past, or the belief that it is sometimes so used, is an important cause of public anxieties about the treatment.
Contraindications
ECU produces a considerable though shortlived increase in cerebral blood flow, and for this reason should not be given to anyone suspected of having raised intracranial pressure. Apart from this there are no absolute contraindications: in severe depression the risk of death may well be greater than any hazard the treatment might pose. As well as increasing cerebral blood flow ED' also produces a series of cardio vascular changes similar to those occurring in the Valsalva manoeuvre, the most important being a shortlived but sudden tachycardia accompanied by a sharp rise in systolic blood pressure (Perrin, 1961) .
For this reason the treatment should be avoided or postponed in those who have recently had a myocar dial infarction, and only given after careful con sideration to anyone known to have a cerebral or aortic aneurysm, or with a history of cerebral haemor rhage. And in view of the series of general anaesthetics involved ED' should generally be postponed in anyone with an acute respiratory infection. Spinal disease and recent limb fractures used to be contraindications but matter little now that limb and spinal movements can be reliably abolished by suxamethonium. Neither indwelling cardiac pace makers nor pregnancy are contraindications. The passage of an electric current across the head does not interfere with pacemakers or precipitate labour, and in early pregnancy ED' may well be preferable to antidepressant or other drugs. Finally, old age is not a contraindication. Although the risks of ED' rise somewhat with increasing age they rise less steeply than the risks of either untreated depression or tricyclic antidepressants. Even frail people in their 80s usually tolerate the treatment well and its efficacy is at leart as good, and possibly better, in old age than it is in earlier decades.
Administration of ECT
(a) The anaesthetic ED' normally involves the administration of atropine, a short-acting barbiturate anaesthetic and a muscle relaxant. Atropine is given partly to reduce bronchial secretions, and partly to inhibit the vagal discharge accompanying the convulsion, and so to minimize the incidence of arrhythmias.
In healthy patients in whom the inhibition of secretions is relatively unimportant the drug can be given i.v. immediately after the anaesthetic rather than sub cutaneously 30â€"60 minutes beforehand and the subject thus spared the discomfort of a dry mouth and the attendant risk of surreptitious drinking. As atropine has cerebral as well as systemic effects the American Psychiatric Association's task force re commended the use of quarternary anticholinergic drugs like methylscopolamine which do not cross the blood brain barrier, though in fact there is no evidence that atropine contributes significantly to post-ED' confusion.
Either methohexitone or thiopentone is normally used as the anaesthetic agent. The former is probably preferable as it has been shown to produce fewer extrasystoles and other ECG abnormalities (Pitts, 1972), but its very short duration of action may be a disadvantage if the patient wakes while still in a state of post-ictal confusion. A minimum dose should be used as barbiturates raise the seizure threshold and it is important not to give patients an inducing shock larger than necessary. On the other hand it is vital that patients are given enoUgh to render them un conscious. The experience of being paralysed with suxamethonium while still conscious is terrifying and patients to whom this has happened are under standably reluctant to have ED' ever again. Except in rare patients with pseudocholinesterase deficiency suxamethonium or suxethonium are the best muscle relaxants because of the profound relaxation they produce and their short duration of action. As soon as the anaesthetic and relaxant have been given 100 per cent oxygen should be administered by mask, but it is important not to hyperventilate the patient as the resulting hypocapnia may prolong seizure duration by several minutes and this is probably undesirable. Oxygen should be given again after the convulsion and continued until spontaneous respiration has returned. In Britain and most other countries it is now normal practice for anaesthesia to be given only by an anaesthetist. This is probably sensible, though it is worth noting that in Heshe and Roeder's recent survey of ECT in Denmark neither the mortality nor the morbidity was any higher when the anaesthetic was given by a psychiatrist or by a nurse. It is vital, however, for whoever gives the anaesthetic to be able to pass an endotracheal tube if the need arises. ED' is still given unmodified in some under developed countries which cannot afford the expense and lack the skilled manpower which an anaesthetic requires. Unmodified ED' is in most respects equally safe and, surprising as this may seem to the onlooker, usually no more frightening for the patient, except by repute, than the modified treatment (Havens, 1958; Huggins ci a!, 1964) . It does, however, involve a considerable risk of spinal and other fractures, produces a greater rise in blood pressure and pulse rate than the modified treatment, and is more often followed by troublesome restlessness. There are therefore cogent medical reasons as well as overriding political ones for never giving ED' without anaesthetic and muscle relaxant except in the special circumstances referred to above.
(b) Electrode placements
When it was first introduced ED' was given with one electrode on either side of the head anterior to the pinna of the ear and this bilateral placement is still more widely used than any other. The idea of putting both electrodes on the same side, usually over the non-dominant hemisphere in order to minimize confusion and memory disturbance, was first mooted and tried out in the l940s, but excited little interest until the l960s, probably because of a lingering suspicion that temporary disturbance of memory might be necessary for the therapeutic effect. In the last twenty years, however, innumerable comparisons between bilateral and a variety of unilateral electrode placements have been carried out. Twenty-one of these were reviewed by Heshe ci a!, (1978) as a prelude to their own. In four of these 21 bilateral electrodes were more effective, in one poorly designed study unilateral electrodes were more effective and in twelve there was no significant difference between the two, though in several of these patients receiving unilateral treatment required a slightly longer course before full recovery was achieved. Almost without exception, studies which have compared the effects of the two on cognitive function have found that, at least in right-handed patients, unilateral electrodes over the right (i.e. non-dominant) hemisphere are associated with less post-ictal confusion' and less memory disturbance in the following 24 hours than bilateral electrodes.
Although most of those who have compared unilateral and bilateral placements have concluded that the former is to be preferred because of this reduction in confusion and memory disturbance, bilateral electrodes are still used by the majority of American (78 per (1958) are probably the most widely used (i.e. one electrode one and a half inches above the mid-point of a line from the lateral angle of the orbit to the external auditory meatus, and the other three inches higher at an angle of 70Â°to that line). If the electrodes are too close together, however, too little current will penetrate the skull and as a result no convulsion, or only a partial convulsion, will result. This is probably the explanation of the frequent find ing that patients receiving unilateral ED' often require one or two more treatments than matched groups receiving conventional bilateral treatment. For this reason it is particularly important when using unilateral electrodes to have an accurate means of ensuring that a bilateral convulsion has been induced. The best way of doing so is to have simultaneous EEG recording; failing that the dose of suxamethonium must be sufficiently small to allow some limb move ments still to occur. The other important issue is that the patient's handedness has to be carefully established beforehand as the effects of using unilateral electrodes over the dominant hemisphere may be worse than those of bilateral electrodes. Indeed in sinistrals, whose dominant hemisphere is less easily predicted than that of dextrals, it may be better to use bilateral electrodes. There is insufficient evidence on this point because most studies of unilateral ED' have de liberately been restricted to dextrals.
(c) Number andfrequency of treatments During the last twenty years there has been a steady reduction both in the frequency of administration of ED' and in the total number of treatments given in a course. This is partly due to an increasing recognition that memory disturbance and confusion are unrelated to the therapeutic effect, and therefore to be avoided, and partly to an increasing restriction of the treatment to depression, which has long been recognised usually to require a shorter course than schizophrenia. In most hospitals it is now customary for ED' to be given two or sometimes three times a week, with an interval of not less than 48 hours between successive treatments.
However, as formal comparisons of different temporal sequences have rarely been carried out it is difficult to be confident that this practice is preferable to, say, one or four treatments a week. Indeed, StrÃ ¶mgren (1975) recently claimed, on the basis of a comparison of two similar but unmatched groups of patients, that if unilateral ED' was given four times a week instead of twice the time needed for recovery was reduced by an average of eleven or twelve days without any increase in memory distur bance. The attempt to hasten recovery by reducing the interval between successive seizures reached its' logical conclusion in the practice of inducing several seizures in succession during a single period of anaesthesia, so-called multiple ED' (MED'). In fact, MED' is still given in one or two centres (e.g. Maletzky, 1978) , though most psychiatrists will require convincing evidence that it does not produce increased confusion and memory impairment before they consider using it. The number of treatments needed to relieve depressive symptoms varies considerably from patient to patient. This means that it is misguided to give patients a standard course of six ED', or any other set number, because some will need more and others less. In most patients between four and eight treat ments are needed, but occasionally two or three will suffice and some people need ten or twelve. improve ment is usually apparent after the first three or four treatments and may be dramatic after the first. Conversely, if the patient has not started to improve after six or eight treatments there is probably little point in continuing further. In the past patients were often given one or two extra treatments after full recovery had been achieved in the hope that this would prevent relapse but a controlled trial by Barton ci a! (1973) failed to demonstrate any benefit. The practice should therefore be abandoned.
(d) The electrical stimulus
Although the passage of an electric current across the head is only one of several possible ways of inducing a convulsion the original alternatives have all been abandoned. The use â€˜¿ of cardiazol and other intravenous convulsant drugs ceased within a few years of the introduction of Cerletti's electrical treatment and photic stimulation was never used other than experimentally.
The convulsant ether flurothyl, which is inhaled like an anaesthetic agent, was used in several countries in the l960s but it fell out of favour because it was more expensive and less convenient than ED', and it is no longer obtainable.
Cerletti originally induced seizures with an alternat ing current of 110 volts for haIfa second and most ED' machines have been based ever since on some modi fication of mains alternating current (i.e. a biphasic sinusoidal waveform with a frequency of 50 or 60 cycles/sec and a voltage of between 110 and 260 volts), though some have used a dischargingcondenser.
Some machines deliver a fixed quantity of electricity, or would do so if head resistance were constant; in others the quantity can be varied either by increasing or decreasing the duration of stimulation or by altering the capacity of the condenser.
Partly because they knew little about electricity, and probably also because authoritative figures like Hoch and Kalinowsky said that the type of electric current used was immaterial, most psychiatrists have taken little interest in either the quantity of electricity or the waveform they were administering to their patients.
Indeed, many published studies of ED' provide no information at all on these matters. Since Ottosson's (1960) experiments were published, however, it has been widely accepted that a supraliminal stimulus increases post-ictal confusion and memory disturbance without any matching increase in therapeutic efficacy, and that the minimum stimulus capable of inducing a convulsion should therefore be used.
Because the resistance of the skull is high only a small fraction of the total current passes through brain. Experiments with animals and cadavers suggest that it may be as low as 6 per cent with standard bitemporal electrodes. Moreover the resistance of the skull varies considerably with its thickness, and is much lower at the site of emissary veins than else where, which means that the quantity of electricity delivered by a â€˜¿ standard' stimulus will also vary considerably even if the scalp is properly prepared. (Although most ED' machines assume a skull resistance of 300 ohms this may vary in practice from 200 to 500 ohms even after adequate skin preparation).
As most ED' machines are set so as to produce a convulsion in the great majority of patients without adjustment, it follows that many patients will be receiving a considerably larger current than they require. Most ED' machines, both those delivering a bi phasic sinusoidal current and those based on a dis charging condenser, normally deliver between 30 and 45 joules over a duration of 0.5 to 1.5 seconds. How ever, much of this current is incapable of contributing to the neuronal discharges provoking the seizure be cause it is delivered while the neurones concerned are in their refractory period. Brief pulses lasting no longer than a millisecond at intervals of between 10 and 40 milliseconds avoid this problem and enable a seizure to be produced with much smaller quantities of electrical energy spread over a longer period (about 5 seconds the ED' machines used in the 14 treatment centres in a single health region in southern England.
Although there was no evidence that any untoward reactions or deaths had ever resulted from faulty apparatus they found 50 faults in the 18 ED' machines in regular use, another 30 faults in the 16 reserve machines, and a serious lack of skilled maintenance generally. This may have been a purely local problem. It seems more likely, though, to be another aspect of the general lack of interest in the specifications and mode of action of ED' machines referred to pre viously.
Public Attitudes to ECT
lt is difficult for psychiatrists, particularly those who see the beneficial effects of ED' on severe depression every week, to understand the widespread appre hension and suspicion which the treatment sometimes arouses in other people. Unfortunately, most laymen have never heard of the diathermy needle or the cardiac defibrillator. Judicial execution and torture are the only other situations they know of in which large electric shocks are deliberately given to human beings, and these unhappy analogies readily colour their image of the treatment. Cerletti himself was well aware of this from the beginning. As he said some years later: â€oe¿ The idea of submitting man to convulsive electric discharges was considered utopian, barbaric and dangerous: in everyone's mind was the spectre of the â€˜¿ electric chair 'â€• (Cerletti, 1956 ). The irony is that ED' was introduced as an alternative to other chemical means of inducing convulsions which did not evoke these unfortunate associations, and supplanted them because for the patient himself it was less frightening and unpleasant than they were.
But we would be deceivingourselves if we sought to explain public anxieties purely in these terms. Part of the reason for the restrictive legislation enacted in the l970s by several American states was the conviction of responsible and well informed people that the treatment was sometimes used as a convenient means of subduing difficult patients, and more frequently administered without adequate regard for the wishes of the patients concerned, or their relatives. It is easy to say that such things do not happen here, but we have the scars of Ely and Whittingham to warn us that they may. It only requires one or two well publicised abuses in a decade to maintain public anxieties, particularly when well-financed organiza tions like the scientologists are waiting to exploit any hint of misuse.
There is no doubt that situations occasionally arise in which ED' needs to be given to patients without their consent. Some patients with severe depressive illnesses are pathologically fearful, others are paranoid and convinced people are trying to kill them. Some refuse all treatment because they do not recognize that they are ill, or because they do not believe they deserve treatment. Others are so indecisive they cannot bring themselves to consent to anything. But these situations are all fairly uncommon. Most patients who initially refuse to have ED', or cannot bring themselves to sign a consent form, are simply worried and frightened, and will change their mind if they are given time to talk to their relatives and other patients who have had the treatment themselves. Although the Mental Health Acts give psychiatrists the power to treat patients against their wishes, and needs to do so, this is a power which, at least where ED' is concerned, should not often have to be used. Freeman and Kendell (1980) interviewed 166 patients who had received ED' in a large Scottish mental hospital in 1971 or 1976. Although 40 per cent remembered feeling at least mildly anxious and frightened before starting the treatment 62 per cent found it less distressing in practice than they had expected. And when asked how ED' compared with going to the dentist 49 per cent described it as â€˜¿ less upsetting' and only 18 per cent as â€˜¿ more upsetting'. This suggests that for the majority of patients ED' is no more unpleasant than many other minor medical procedures, though it is often viewed with appre hension beforehand. Forty-nine per cent of these patients were convinced, however, that they had never been given an adequate explanation of what the treatment involved, and only 21 per cent regarded the explanation they had been given as adequate. Although the authors of this study knew from personal experience that some of these 49 per cent had been given a detailed explanation, post-ED' amnesia is hardly a plausible explanation overall. It seems more likely that medical staff do often fail to explain what the treatment involves when asking patients for their consent. Very similar opinions have recently been obtained from a consecutive series of 80 patients receiving ECT in Southampton (Hughes ci a!, 1981).
Eighty-three per cent said the treatment had helped them, 81 â€˜¿ per cent said they would have it again if need be, and 54 per cent described it as less frightening than a visit to the dentist. But once more 49 per cent said the treatment had not been properly explained beforehand.
Except in the aftermath of some quite unforseen tragedy there is little risk in this country of the kind of restrictive legislation that has been enacted in some American states. The evidence for the efficacy and safety of ED' is too strong, and Parliament has always been commendably reluctant to interfere in matters of clinical judgement. The greater risk is that unfavourable publicityâ€"perhaps the deliberate ex ploitation of a genuine but isolated incidentâ€"will make patients who need to have ED' reluctant to do so, and psychiatrists themselves reluctant to use the treatment as often as they should.
Implications for Clinical Practice and Future Research
ED' is a â€˜¿ surgical' rather than a â€˜¿ medical' treatment and for that reason alone it is likely that it will eventually be supplanted' by some form of drug therapy. Indeed, one must assume that the convulsion is inducing changes in cerebral function which ought in principle to be reproducible by pharmacological means. Until drugs of comparable efficacy and safety are developed, however, it is essential that ED' should remain freely available on the same terms as any other treatment. Psychiatrists have too few effective therapies at their disposal to be able to afford the luxury of dispensing with what is still the most dramatically effective of them all.
The unfavourable publicity that was at its height in 1975â€"77 has had a number of beneficial as well as adverse effects. It has stimulated some important new research, and caused other important work carried out in the l950s and l960s to be rediscovered. It has also revealed a rather casual attitude to the treatment in many hospitals. Although the recent College survey will shed more light on the true state of affairs it seems likely that there are too many places where ED' machines are not properly inspected and maintained, where the treatment is administered by a constantly changing rota of junior staff who are not adequately trained or supervised, and where the nature and purpose of the treatment are inadequately explained to patients beforehand. The need for a comprehensive re-examination of existing procedures should not need emphasizing in the present climate of opinion and it is much to be hoped that the College's survey will serve as stimulus to such a review.
The priorities for future research seem equally clear. It is fairly well established that the therapeutic effects of ED' are due to convulsive activity in the brain, and the work of Modigh in Gotenberg and Smith in Oxford has shown that series of convulsions induced over a similar time span to ED' produce changes in transmitter function in laboratory animals analogous to those produced by antidepressant drugs.
Even if the particular changes in postsynaptic receptor sensitivity they identified prove to be unimportant this line of enquiry is obviously worth pursuing further, both in animals and humans. For it holds out the prospect of elucidating which of the many biochemical changes induced by the convulsions are responsible for the therapeutic effect. If this could be achieved it would not only be of great theoretical interest; it might also lead to the development of new drugs capable of producing the same effect without tI@e need for either convulsion or anaesthetic.
It is obviously important that the long-term effects of ED' on the fine detail of past memory should be studied further in the light of recent evidence that a course of 8 or 9 bilateral ED' given at a rate of 3/week may produce lasting deficits. It is unlikely that unilateral treatment does so but the matter needs investigating quickly, and so does the effect of bilateral ED' when given only twice a week. Further studies of the effects of ED' on the EEG would also be worth while. It was never completely established that the extensive temporary changes that ED' produces were never followed by permanent changes when the matter was investigated in the l950s, and even if it had been the advances in EEG technology that have taken place in the last twenty years make the issue worth reopening.
The conflicting results of recent comparisons of the effect of real and simulated ED' in the treatment of depressive illness and the attendant publicity make it almost inevitable that further trials of this kind will be mounted. If so, it is to be hoped that they will not confine themselves to the issue of short-term efficacy, but will also examine the duration of benefit as the Northwick Park trial did. The situation is different where mania and schizophrenia are concerned. In both these conditions there isprimafacie evidence that ED' was an effective treatment in the days before it was displaced by phenothiazine drugs. We know little, however, about its possible value in patients with mania or schizophrenia who do not respond ade quately to phenothiazine or other drugs, and this is the one situation in which ED' might be of real value in contemporary practice. Appropriate clinical trials would, therefore, be very welcome, though they would probably have to be multicentre trials in view of the small numbers of patients likely to meet entry criteria.
Finally, there is a pressing need for systematic investigation of the relative therapeutic and adverse effects of different types of electrical stimulus, and of increasing or decreasing the duration of convulsive activity in the brain. In the last fifteen years there have been a large number of rather repetitive studies of the relative merits of unilateral and bilateral electrodes. Much less interest has been taken in either the characteristics of the inducing stimulus or the duration of convulsive activity. The studies of Valentine ci a! (1968) and Weaver ct a! (1977) suggest that a brief pulse stimulus has important advantages over the conventional sinusoidal stimulus. On the other hand the anomalous clinical trial of Lambourn and Gill (1978) raises the possibility that convulsions induced by brief pulse stimuli may be less effective. Similarly, Ottosson's classical study suggested twenty years ago that reducing the duration of convulsive activity in the brain reduced therapeutic efficacy. Yet despite the general belief that convulsive activity in the brain is the crucial ingredient, the availability of means of both shortening and lengthening its duration, and the flaws in Ottosson's design, experiments of this type have never been repeated. It seems clear, therefore, that a well-designed investigation of either of these issues would be likely to yield results of both theo retical and practical importance.
